Filing Details
- Accession Number:
- 0001209191-22-040099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-01 15:08:15
- Reporting Period:
- 2022-06-01
- Accepted Time:
- 2022-07-01 15:08:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1695580 | Kenneth Krogulski | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-06-01 | 127 | $2.05 | 187,744 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-02 | 127 | $2.08 | 187,871 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-03 | 127 | $2.09 | 187,998 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-06 | 136 | $2.07 | 188,134 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-07 | 100 | $2.08 | 188,234 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-08 | 136 | $2.12 | 188,370 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-09 | 136 | $2.09 | 188,506 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-10 | 136 | $2.04 | 188,642 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-13 | 136 | $2.01 | 188,778 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-14 | 136 | $2.02 | 188,914 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-15 | 136 | $1.98 | 189,050 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-16 | 136 | $1.95 | 189,186 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-17 | 136 | $1.94 | 189,322 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-21 | 143 | $1.97 | 189,465 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-22 | 139 | $1.99 | 189,604 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-23 | 143 | $2.01 | 189,747 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-24 | 143 | $2.11 | 189,890 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-27 | 26 | $2.06 | 189,916 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-28 | 132 | $2.06 | 190,048 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-29 | 143 | $2.11 | 190,191 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2022-06-30 | 143 | $2.08 | 190,334 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.
Billionaire Hedge Funds
